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Abstract
Background: Corticotropin-releasing factor overexpressing (CRF-OE) male mice showed an inhibited feeding
response to a fast, and lower plasma acyl ghrelin and Fos expression in the arcuate nucleus compared to wild-type
(WT) mice. We investigated whether hormones and hypothalamic feeding signals are impaired in CRF-OE mice and
the influence of sex.
Methods: Male and female CRF-OE mice and WT littermates (4–6 months old) fed ad libitum or overnight fasted
were assessed for body, adrenal glands and perigonadal fat weights, food intake, plasma hormones, blood glucose,
and mRNA hypothalamic signals.
Results: Under fed conditions, compared to WT, CRF-OE mice have increased adrenal glands and perigonadal fat
weight, plasma corticosterone, leptin and insulin, and hypothalamic leptin receptor and decreased plasma acyl
ghrelin. Compared to male, female WT mice have lower body and perigonadal fat and plasma leptin but higher
adrenal glands weights. CRF-OE mice lost these sex differences except for the adrenals. Male CRF-OE and WT mice
did not differ in hypothalamic expression of neuropeptide Y (NPY) and proopiomelanocortin (POMC), while female
CRF-OE compared to female WT and male CRF-OE had higher NPY mRNA levels. After fasting, female WT mice lost
more body weight and ate more food than male WT, while CRF-OE mice had reduced body weight loss and
inhibited food intake without sex difference. In male WT mice, fasting reduced plasma insulin and leptin and
increased acyl ghrelin and corticosterone while female WT showed only a rise in corticosterone. In CRF-OE mice,
fasting reduced insulin while leptin, acyl ghrelin and corticosterone were unchanged with no sex difference. Fasting
blood glucose was higher in CRF-OE with female > male. In WT mice, fasting increased hypothalamic NPY
expression in both sexes and decreased POMC only in males, while in CRF-OE mice, NPY did not change, and
POMC decreased in males and increased in females.
Conclusions: These data indicate that CRF-OE mice have abnormal basal and fasting circulating hormones and
hypothalamic feeding-related signals. CRF-OE also abolishes the sex difference in body weight, abdominal fat, and
fasting-induced feeding and changes in plasma levels of leptin and acyl ghrelin.
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Background
Corticotropin-releasing factor overexpressing (CRF-OE)
mice have chronic elevation of CRF mainly in the brain
regions that normally express CRF [1, 2]. These transgenic
mice display Cushing-like features [1, 3, 4], namely elevated
plasma levels of the adrenocorticotropic hormone (ACTH)
and corticosterone, truncal obesity, muscle wasting, thinner
skin, hair loss, immunosuppressive phenotype and insulin
resistance linked with the chronic activation of the
hypothalamic-pituitary-adrenal (HPA) axis. In addition,
CRF-OE mice recapitulate key behavioral and autonomic
features of chronic stress which result from CRF overdrive
within the brain. These include anti-sexual and anxiogenic
behaviors [5–7], reduced attention [8], brain atrophy [9], ex-
aggerated defecation and voiding response to novel acute
environment stress [10], increased body temperature and
heart rate [2], and reduced fertility in females [1]. We previ-
ously reported that female CRF-OE mice also showed a
more sensitive pelvic visceral response to a novel environ-
ment than males [10]. Further studies by Valentino et al.
[11] established that CRF-OE mice display a sex difference
in CRF receptor 1 trafficking in the locus coeruleus norad-
renergic neurons rendering females more sensitive to high
levels of CRF [12]. Therefore, transgenic CRF-OE mice with
CRF overdrive in the brain—while showing a phenotype
similarly to Cushing’s syndrome—serve also as a relevant
model to gain insight in the functional and behavioral con-
sequences of chronic exposure to stress [2, 13–15] and to
assess sex differences under these conditions [10, 12]. It is
to note that CRF-OE mice have differential etiology of
hyperglucocorticoidemia compared to that induced in
Cushing’s disease which usually results from tumors in the
pituitary or adrenal glands, and occasionally by ectopic
ACTH production [16] with an incidence of three to eight
times higher in women than in men [17].
We also found that male CRF-OE mice exposed to over-
night food deprivation had a reduced refeeding response
compared with wild-type (WT) littermates along with de-
creased Fos expression in the hypothalamic arcuate nucleus
[18], suggestive of an altered homeostatic response to food
deprivation. The hypothalamus is one of the major integra-
tive centers regulating food intake and energy balance [19,
20]. In particular, neurons in the arcuate nucleus bearing
neuropeptide Y (NPY) and proopiomelanocortin (POMC)
integrate signals derived from the adipose tissue such as
leptin and circulating peptides released from the endocrine
cells of the gastrointestinal tract and the pancreas [20].
There is also evidence that obesity alters the fasting and
postprandial levels of gut hormones [21]. Therefore, we
hypothesized that chronic brain overexpression of CRF and
increased visceral adipose tissue in CRF-OE mice [3, 9, 22]
could alter the pattern of peripheral hormones and
hypothalamic peptides under basal conditions and their
response to a fast. Moreover, taking into account the role of
sex hormones in the regulation of energy metabolism and
the inhibitory actions of glucocorticoids and CRF on the
hypothalamic gonadal axis [7, 23, 24], it was important to
delineate potential sex differences under these conditions.
In the present study, we first assessed the weights of
body, perigonadal adipose tissue, and adrenal glands
under basal and fasting conditions in male and female
CRF-OE mice compared to WT littermates and their food
intake response to an overnight fast. Then, we determined
the blood glucose and plasma levels of corticosterone,
leptin, insulin, acylated (acyl) ghrelin, peptide tyrosine
tyrosine (PYY), and pancreatic polypeptide (PP) known to
regulate food intake and energy balance [25, 26]. We also
investigated whether hypothalamic expression levels of
NPY, POMC and leptin receptor were altered in CRF-OE
mice. Lastly, based on reports that the hypothalamic acti-
vation of CRF receptor 2 (CRF2) suppresses feeding and
that CRF2 transcript is decreased in obese rats [27, 28], we
assessed whether hypothalamic CRF2 expression would be
altered by fasting in CRF-OE mice.
Methods
Animals
CRF-OE mice were bred by the animal core of the UCLA
Center for Neurobiology of Stress (Dr. M. Fanselow, Depart-
ment of Psychology). The source of transgenic line was as
originally detailed [1] using the chimeric CRF transgene
composed of the rat CRF gene and the 5′ regulator region
replaced by mouse methallothionein-1 promoter microin-
jected into the male pronucleus of fertilized eggs (C57BL/
6 × SJL). Mice were backcrossed over ten generations and
genotyped using PCR to amplify DNA from the tail as
previously detailed [1]. These mice exhibited CRF overpro-
duction mainly in the brain areas, while neither CRF gene
was detected by Northern blot analysis in the peripheral tis-
sues except at low levels in the testes nor CRF peptide in the
plasma by radioimmunoassay [1]. Adult male and female
CRF-OE mice and WT littermates (4–6 months old) were
group housed with free access to water and standard rodent
chow (Prolab RMH 2500, 5P14, LabDiet, St. Louis, MO)
and maintained under controlled conditions of temperature
(20–23 °C), humidity, and lighting with a 12-h light/dark
cycle (06:00–18:00 hours). Animal care was conducted in
accordance with the United States Public Health Service
Guide for the Care and Use of Laboratory Animals. The pro-
cedures were approved by the Animal Research Committee
at VA Greater Los Angeles Healthcare System (# 04012-06).
Fasting and food intake measurements
To minimize the stress of novel environment linked with
the assessment of refeeding after a fast, mice were first ha-
bituated to overnight individual housing in a standard cage
with a wire grid without food deprivation twice at a 3-day
interval. The wire grid was used to avoid coprophagia
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during fasting. Fasting/refeeding experiments were per-
formed by placing male and female CRF-OE mice and WT
littermates in the individual cage with wired bottom and re-
moving the food overnight and maintaining free access to
water. Body weight was monitored before and after fasting.
The access to food after the overnight fast started about
09:00 hours (time zero), and food intake was monitored up
to 13:00 hours as detailed in our previous studies [18]. In
brief, pre-weighed chow was provided at time 0 and at each
subsequent time intervals: 0.5, 1, 2, and 4 h, the remaining
food and spillage were removed and replaced by new pre-
weighed chow. The amount of food intake was determined
by the difference between the values of pre-weighed chow
and the weight of chow and spillage at the end of each time
period.
Blood and tissue collections
Male and female CRF-OE and WT mice were randomly
assigned to ad libitum feeding or overnight fasting and
deeply anesthetized with an overdose of isoflurane between
9:00 and 11:00 hours. Blood (~0.5 ml) was withdrawn im-
mediately from the heart after thoracotomy and transferred
in ice-chilled tubes containing ethylenediaminetetraacetic
acid (EDTA, 7.5%, 10 μl/0.5 ml blood; Sigma-Aldrich Co.,
St. Louis, MO). Protease inhibitors were added (EDTA-free
protease inhibitor cocktail tablets: cOmplete™, Mini, Roche
Applied Sciences, IN; aprotinin 780 KIU; MP Biomedicals,
LLC, Solon, OH). Samples were kept on ice and centrifuged
at 3000 rpm at 4 °C for 5 min and plasma samples were
stored at −80 °C until hormone assays. Adrenal glands and
perigonadal adipose tissue were removed bilaterally and
weighed. The hypothalamus was dissected out, frozen on
dry ice, and stored at −80 °C until RNA extraction.
Hormone assays
Plasma corticosterone levels were determined using radio-
immunoassay (07-120102, MP Biomedicals, LLC, Solon,
OH). The limit of the assay sensitivity was 7.7 ng/ml and
the intra-assay variations were less than 4.4%. Plasma levels
of insulin, leptin, acyl ghrelin, PYY, and PP were quantified
using the mouse gut hormone panel kit by Luminex xMAP
(cat. # MGT-78K; Millipore Corporation, Billerica, MA).
All samples were processed in one batch and analyzed with
the Luminex 100 (Luminex Corporation, Austin, TX). The
intra-assay variations were 6.2% for insulin, 9.5% for leptin,
5.5% for acyl ghrelin, 4.5% for PYY, and 6.7% for PP. This
technology allows the simultaneous determination of
multiple hormones and cross-reactivity between the anti-
bodies, and any other analytes of this panel is negligible
(manufacturer’s information, Millipore).
Quantitative real-time PCR
The hypothalamus smaples were homogenized and total
RNAs were extracted by the phenol-quanidine thiocyanate-
chloroform method (TRIzol®, Invitrogen, Carlsbad, CA) fol-
lowing the manufacturer’s recommended protocol. First-
strand oligo-dT primed cDNA was synthesized from total
RNA (1 μg) of each sample using the ThermoScript™ RT-
PCR system (Invitrogen, Carlsbad, CA). The hypothalamic
NPY, POMC, and leptin and CRF2 receptors were detected
by real-time PCR using the DNA Engine Opticon® 2 Detec-
tion System interfaced to the Opticon MONITOR™ analysis
software version 2.01 (MJ Research Inc., Waltham, MA) in
a 25-μl reaction volume. The primers’ sequences are listed
in Table 1. The optimized reaction contained 12.5 μl of
SYBR® Premix Ex Taq™ (Perfect Real Time, Takara Mirus
Bio Inc., Madison, WI), 0.5 μl of oligonucleotide primers
(10 μM), 1 μl of the cDNA synthesis reaction, and 10.5 μl
of H2O. Thermal conditions were as follows: 95 °C for
4 min, followed by 40 cycles of 95 °C for 5 s and 60 °C for
60 s. The specificity of the amplification reaction was deter-
mined by performing a melting curve analysis of the PCR
fragments. Data were quantified using the comparative
cycle threshold (Ct) method. For each sample, Ct was
normalized to S16 and the final value 2−ΔΔCt was adjusted
so that the control had a mean relative mRNA level of 1 as
previously described [29].
Statistical analysis
Data were analyzed by one-way ANOVA, and interactions
between genotypes, feeding status, and sex were analyzed
by two-way or three-way ANOVAs followed by Tukey’s
post hoc tests. Correlations between hormone levels,
blood glucose, and tissue weights were performed by
linear regression analyses. Data are expressed as mean ±
SEM. P < 0.05 was considered significant.
Results
Body and perigonadal fat weights and food intake
response to overnight fast: influence of sex and
CRF-OE genotype
Body weight
Under basal conditions (ad libitum feeding), adult 4–6-
month-old female WT mice had a significant 28% lower
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body weight than male WT which was not present in CRF-
OE mice (Fig. 1a). Namely, female CRF-OE had a 30%
increase in body weight compared to female WT, while
male CRF-OE and WT mice had similar weights (Fig. 1a).
Two-way ANOVA analysis showed a significant interaction
of sex and genotype (F1,35 = 47.7, P < 0.001). After an over-
night food deprivation, the body weight was reduced by 9.9
± 0.8 and 12.1 ± 0.4% in male and female WT, respectively
(P < 0.01), with a significant sex difference (Fig. 1b). Male
and female CRF-OE mice had a similar reduction of their
body weight by fasting in both sexes (7.6 ± 0.3 and 7.6 ±
0.3%, respectively; Fig. 1b), and the reduction was signifi-
cantly lower compared to WT mice of the same sex (F1,32
= 63.5, P < 0.001). Three-way ANOVA showed an impact of
sex in WT mice (F1,32 = 6.8, P < 0.05) and an interaction be-
tween sex and genotype (F1,32 = 6.5, P < 0.05).
Perigonadal fat
Under basal conditions, the perigonadal fat weights
expressed per 25 g of body weight were 49% lower in fe-
male than in male WT mice, and 88 and 231% higher in
male and female CRF-OE, respectively, compared with WT
mice of the same sex (Fig. 1c; P < 0.001). However, there
was no significant difference between male and female
CRF-OE mice as observed in the WT group (Fig. 1c).
Fasting led to a significant 52% reduction in perigonadal fat
weight in WT males while in females, it did not reach stat-
istical significance (Fig. 1c). In male and female CRF-OE
mice, the perigonadal tissue weights were not modified by
fasting and there was no sex difference (Fig. 1c). Two-way
ANOVA showed a highly significant influence of genotypes
(F1,47 = 160.8, P < 0.001) and of sex (F1,47 = 28.3, P < 0.001).
Food intake
The food intake measurements repeated twice in the
same cohort of WT and CRF-OE male and female mice
showed similar results. The 4-h cumulative feeding re-
sponse to an overnight fast was 1.5-fold higher in female
than in male WT mice calculated per 25 g body weight
(P < 0.05; Fig. 2a). At 0.5-, 1-, 2-, and 4-h time periods of
refeeding, male CRF-OE mice had 75, 82, 88, and 81%
lower cumulative food intake than male WT mice, re-
spectively (P < 0.05), and similarly, female CRF-OE mice
had a 75, 84, 88, and 85% reduction compared to female
WT mice (P < 0.05; Fig. 2a), respectively. The reduction
of food intake was highly correlated with that of body
weight (r2 = 0.73, P < 0.001; Fig. 2b).
Increased adrenal gland weights with sex difference and
plasma levels of corticosterone in CRF-OE mice
There were no differences in the adrenal glands weights
between the left and right sides and between fasted and
non-fasted mice (data not shown); thus, the adrenal
weights reflect the bilateral pooled values for each
mouse and data are expressed in the same genotype and
sex group irrespective of feeding status. The larger ani-




Fig. 1 Body weight under normal feeding (a) and percentage change
after fasting (b) and weights of perigonadal fat per 25 g of body
weight under basal and after fasting (c) of male and female CRF-OE
mice and wild-type littermates (WT). The number of mice/group is
indicated at the bottom of each bar in graph. Data are mean ± SEM.
*P < 0.05 vs. WT mice of same sex; +P < 0.05 vs. male WT
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assessment reflects data included from previous experi-
ments [9, 18] in which the adrenal glands’ weight was
not reported. The weights of the adrenals showed differ-
ences in sex and genotypes with larger adrenals in fe-
males than in males of both WT (5.7 ± 0.3 vs. 3.8 ±
0.3 mg, respectively; P < 0.05) and CRF-OE mice (11.6 ±
0.6 vs. 8.9 ± 0.3 mg, respectively; P < 0.001), with values
in CRF-OE >WT (P < 0.001; Fig. 3a). The significance
was attributed to sex (F1,47 = 28.28, P < 0.001) and geno-
type (F1,47 = 160.88, P < 0.001).
Basal, early light phase, and plasma corticosterone
levels were 4.6- and 3.3-fold higher in male and female
CRF-OE, respectively, than in WT mice of the same sex
under conditions of ad libitum feeding (Fig. 3b). There
was no sex difference in both genotypes (two-way
ANOVA, sex × genotype, F1,16 = 0.53, P > 0.05). Over-
night fasting increased plasma corticosterone in WT
mice to the same levels as those in non-fasted CRF-OE
mice, while in CRF-OE mice, the plasma corticosterone
was not further increased and there was no sex differ-
ence in both genotypes (P > 0.05; Fig. 3b).
The basal plasma corticosterone levels were highly
correlated with the weights of the adrenal glands (r2 =
0.83; Fig. 3c) and perigonadal fat (g/25 g body weight
(BW)) (r2 = 0.71; Fig. 3d), and the latter two were also
correlated (r2 = 0.67; Fig. 3e).
Plasma levels of metabolic hormones induced by
overnight fast: influence of CRF-OE and sex
Leptin (Fig. 4a)
Basal plasma leptin levels were 0.9-fold lower in female
than in male WT mice (P < 0.05). Overnight fasting
decreased the levels in male WT by 3.2-fold (P < 0.05),
while they were not significantly modified in female WT
mice. By contrast, CRF-OE male and female mice had simi-
larly elevated plasma leptin levels under basal conditions,
which were 1.9- and 6.8-fold higher, respectively, than those
in WT mice of the same sex (P < 0.05), and not significantly
altered by an overnight fast in both sexes. Three-way
ANOVA showed an influence of genotype, fasting, and an
interaction between sex and genotype (Table 2).
Insulin (Fig. 4b)
Under basal conditions, plasma insulin levels in male and
female WT mice were low and significantly reduced after
an overnight fast by 91.7% in male WT mice (P < 0.05) and
not significantly in female WT mice. There was no sex dif-
ference in both conditions. By contrast, CRF-OE mice had
high insulin values (P < 0.001) that were similar in males
and females and decreased after an overnight fast by 87.6
and 87.2%, respectively; however, the levels were still signifi-
cantly 12.6- and 8.8-fold higher than those in male and fe-
male WT mice, respectively (P < 0.05). Three-way ANOVA
showed a significant effect of genotype, fasting, and an
interaction between feeding and genotypes (Table 2).
Acyl ghrelin (Fig. 4c)
Plasma acyl ghrelin levels were not significantly different
in male and female WT mice under ad libitum feeding
conditions. Overnight fasting resulted in a 2.4-fold in-
crease in plasma acyl ghrelin in male WT mice (P < 0.05),
while levels did not change in WT females. By contrast,
CRF-OE mice compared to WT mice had reduced acyl
ghrelin levels (P < 0.001) that were similar in males and fe-
males under basal and overnight fasted conditions. Three-
way ANOVA showed a significant effect induced by geno-
type, fasting, and an interaction between feeding status
and sex and by genotype × sex × feeding status (Table 2).
PYY (Fig. 4d)
Plasma PYY levels were similar in male and female WT
and CRF-OE mice under basal ad libitum conditions.
Overnight fasting significantly reduced PYY values by
0.4-fold only in male mice of both genotypes (P < 0.05).
Three-way ANOVA showed significant influences in-
duced by fasting and sex (Table 2).
a b
Fig. 2 Cumulative food intake after overnight fasting (a) and correlation between body weight reduction and 4-h cumulative food intake (b) in
male and female wild-type (WT) and CRF-OE mice. The number of mice/group is indicated at the bottom of each bar in graph a and b. Data are
mean ± SEM, n = 4–5/group. *P < 0.05 vs. WT mice of same sex; +P < 0.05 vs. male WT. M male, F female
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PP
No significant change in plasma PP was detected by one-
way ANOVA with post hoc comparison among groups as
there were large individual differences (Additional file 1:
Figure S1), while three-way ANOVA showed a significant
impact of genotype, namely CRF-OE vs. WT (Table 2).
Correlation between hormones and perigonadal fat
Under basal fed conditions, there was a highly positive cor-
relation between plasma levels of corticosterone and insulin
(r2 = 0.81, P < 0.001) and leptin (r2 = 0.45, P = 0.001) and a
negative correlation with acyl ghrelin (r2 = 0.31, P < 0.05;
Additional file 1: Figure S2). Basal plasma PYY and PP
levels were also correlated (r2 = 0.62, P < 0.001; Additional
file 1: Figure S3A). Low correlations were observed between
insulin and leptin, insulin and acyl ghrelin, and acyl ghrelin
and leptin (r2 = 0.25, 0.37, and 0.26, respectively, P < 0.05;
Additional file 1: Figure S3B–D). Under fasted conditions,
plasma levels of leptin and insulin were highly correlated
(r2 = 0.64, P < 0.001, Additional file 1: Figure S4). Other hor-
mones had low or no correlations (data not shown).
The perigonadal fat (g/25 g BW) was correlated with
leptin (Additional file 1: Figure S5A) or insulin (Add-
itional file 1: Figure S5B) and inversely with acyl ghrelin
(Additional file 1: Figure S5C) both under basal (r2 =
0.66, 0.58, and 0.45, respectively, P < 0.001) and fasting
conditions (r2 = 0.52, 0.69, and 0.45, respectively, P <





Fig. 3 Weights of the adrenal glands (a) and plasma levels of corticosterone (b) of male and female CRF-OE mice and WT littermates. Data are mean
± SEM. The number of mice/group is indicated at the bottom of each bar. *P < 0.05 vs. WT mice of the same sex (vs. non-fasted WT in graph c);
#P < 0.05 vs. non-fasted male WT mice, and +P < 0.05 vs. male mice of the same genotype. NF non-fasted. Correlation between plasma corticosterone
levels and weights of adrenal glands (c), corticosterone levels and perigonadal fat (d), and weights of adrenal glands and perigonadal fat (e)
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Hyperglycemia in CRF-OE mice with sex differences
After an overnight fast, levels of blood glucose were
similar in male and female WT mice (89.5 ± 3.7 vs. 83.0
± 2.2 mg/dL, P > 0.05; Fig. 5a). CRF-OE mice had signifi-
cantly higher fasting blood glucose levels than WT mice
(Fig. 5a) with a sex difference (127.4 ± 6.6 and 170.7 ±
9.0 mg/dL in males and females, respectively, P = 0.002).
Two-way ANOVA showed significant effects of sex
(F1,16 = 5.67, P < 0.05) and genotype (F1,16 = 66.04, P <
0.001) and an interaction between sex and genotype
(F1,16 = 10.39, P = 0.005).
Blood glucose levels in fasted CRF-OE and WT mice
were positively correlated with plasma levels of leptin (r2 =
0.61, P < 0.001) and insulin (r2 = 0.41, P < 0.001; Fig. 5b, c)
and, to a smaller extent, negatively with acyl ghrelin (r2 =
0.28, P < 0.05) and PP (r2 = 0.24, P < 0.05), but not with
plasma PYY (data not shown). Blood glucose was also
correlated with body weight and perigonadal fat after
fasting (r2 = 0.57 and 0.54, respectively, P < 0.001).
Hypothalamic expression levels of NPY and POMC and
leptin receptor: influence of fasting and genotype
NPY mRNA (Fig. 6a)
In mice fed ad libitum, hypothalamic NPY mRNA
levels detected by real-time PCR were similar in WT of
both sexes and male CRF-OE mice. Overnight fasting
significantly increased NPY mRNA expression by 55.4
and 89.1% in male and female WT mice, respectively,
a b
c d
Fig. 4 Mouse gut hormone panel assay by Luminex xMAP technology for plasma insulin (a), leptin (b), acyl ghrelin (c), and PYY (d) in male and
female fasted and non-fasted CRF-OE mice and WT littermates. Data are mean ± SEM, n = 4–5/group. *P < 0.05 vs. WT mice of same sex under the
same feeding status; #P < 0.05 vs. non-fasted mice of the genotype; +P < 0.05 vs. male mice of the same genotype and feeding status
Table 2 Influence of genotype, fasting, and sex on plasma levels of hormones analyzed by three-way ANOVA (F1,32)
Genotype Fasting Sex Genotype × fasting Genotype × sex Sex × fasting Genotype × fasting × sex
Corticosterone 21.99, P < 0.001 15.11, P < 0.001 n.s. 7.25, P < 0.05 n.s. n.s. n.s.
Leptin 49.35, P < 0.001 5.36, P < 0.05 n.s. n.s. 5.27, P < 0.05 n.s. n.s.
Insulin 82.15, P < 0.001 67.19, P < 0.001 n.s. 49.93, P < 0.001 n.s. n.s. n.s.
Acyl ghrelin 42.16, P < 0.001 6.14 P < 0.05 n.s. n.s. n.s. 6.80, P < 0.05 6.90, P < 0.05
PYY n.s. 12.55, P = 0.001 5.47, P < 0.05 n.s. n.s. n.s. n.s.
PP 9.39, P < 0.05 n.s. n.s. n.s. n.s. n.s. n.s.
PYY peptide tyrosine tyrosine, PP pancreatic polypeptide, n.s not significant
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compared with non-fasted WT mice of the same sex
and remained unchanged in fasted male CRF-OE mice.
By contrast, female CRF-OE mice had 50.5% higher
basal hypothalamic NPY mRNA level than WT females
which was not changed after overnight fasting. Three-




Fig. 5 Fasting levels of blood glucose (a) and its correlation to
fasting plasma leptin (b) and insulin (c) Data are mean ± SEM. The
number of mice/group is indicated in each bar of graph a. *P < 0.05




Fig. 6 Hypothalamic transcript levels of NPY (a), POMC (b), and
leptin receptor (c) in male and female CRF-OE mice and WT
littermates under basal or fasted conditions detected by quantitative
real-time PCR. The number of mice/group is indicated in each bar.
Data are mean ± SEM, n = 4–5/group. *P < 0.05 vs. non-fasted
WT mice
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= 20.3, P < 0.001), feeding status (F1,30 = 18.3, P < 0.001),
sex × genotype (F1,30 = 6.5, P = 0.016) and feeding sta-
tus × genotype (F1,30 = 15.8, P < 0.001).
POMC mRNA (Fig. 6b)
The basal POMC expression was not significantly different
in both male and female WT and CRF-OE mice. In males,
an overnight fast decreased the POMC mRNA levels by
69.2 and 49.0% in WT and CRF-OE mice, respectively. By
contrast, in females, fasting did not modify POMC mRNA
levels in WT and increased it by 66.7% in CRF-OE mice.
Three-way ANOVA displayed significant influence by sex
(F1,30 = 28.3, P < 0.001), genotype (F1,30 = 11.4, P = 0.002),
feeding status (F1,30 = 5.9, P = 0.021), and sex × feeding
status (F1,30 = 17.9, P < 0.001).
Leptin receptor mRNA (Fig. 6c)
The basal and fasting levels of hypothalamic leptin recep-
tor (LepR) mRNA were similar in male and female WT
mice. In CRF-OE, basal LepR expression levels were in-
creased significantly by 29.8 and 45.0% in male and female
mice, respectively, compared with same sex WT mice and
not significantly modified by fasting. Three-way ANOVA
displayed significant influence only by genotype (F1,30 =
30.4, P < 0.001).
CRF2 receptor mRNA
The CRF2 transcript levels in the hypothalamus were not
influenced by either fasting or non-fasting conditions or
genotype (WTand CRF-OE) of the mice (data not shown).
Correlation between the hypothalamic signals with
circulating hormones and perigonadal fat
The expression of NPY in the hypothalamus displayed no
significant correlation with peripheral hormones when all
mice were analyzed together (data not shown). In non-
fasted male and female CRF-OE and WT mice, the NPY
mRNA levels were correlated with those of LepR (P <
0.40) and to a smaller extent with plasma leptin (P < 0.25;
Additional file 1: Figure S7A–B). In overnight fasted male
and female CRF-OE and WT mice, NPY expression was
correlated POMC mRNA levels and perigonadal fat
(Additional file 1: Figure S7C, D). In male CRF-OE and
WT mice under basal and fasting conditions, NPY expres-
sion was correlated with plasma ghrelin and negatively with
leptin and perigonadal fat (Additional file 1: Figure S7E–G),
which were not detected in female mice (data not shown).
The correlations between the hypothalamic POMC
mRNA and plasma acyl ghrelin levels were found in
different conditions, namely basal and fasting, all mice
and males (Additional file 1: Figure S8A–D), while with
LepR mRNA, the correlation was very high in fasted
male and female CRF-OE and WT mice (Additional file
1: Figure S8E, F).
The hypothalamic LepR expression was correlated
with plasma leptin levels in all mice under basal and
fasting conditions (Additional file 1: Figure S9).
Discussion
CRF transgenic mice with elevated CRF expression primar-
ily occurring in the brain and related to enlargement of ad-
renals and hypercorticosteronemia [1–3], display increased
plasma levels of insulin and leptin, low circulating acyl
ghrelin, and upregulation of leptin receptor expression in
the hypothalamus compared to WT littermates. After an
overnight fast, CRF-OE mice have hyperglycemia, maintain
elevated leptin plasma levels, show no rise in acyl ghrelin,
and inhibit refeeding response compared to WT mice.
Moreover, the sex differences in body weight, perigonadal
fat, and leptin plasma with lower levels in WT no longer
exist in CRF-OE mice. Additionally, the adaptive response
to an overnight fast which showed sex differences in WT
mice in the percentage of body weight change, perigonadal
fat weight, food intake, and alterations of insulin, leptin,
and ghrelin plasma levels are also lost in CRF-OE mice.
However, unlike WT mice, CRF-OE mice display sex differ-
ences in the fasting hyperglycemia and hypothalamic NPY
and POMC mRNA levels with females >males. These find-
ings point to the impact of chronic CRF expression in the
brain in altering aspects of adaption to metabolic stress and
sex differences.
Adrenal glands, corticosterone, and abdominal obesity
Chronic intracerebroventricular infusion of CRF in rats re-
sulted in adrenal hypertrophy [30]. Likewise, under condi-
tion of CRF-OE expression primarily in specific brain
nuclei [1, 2], the adrenal glands’ weight was significantly
higher in CRF-OE than in WT mice and there was a sex
difference (females >males) in both genotypes consistent
with previous reports [3, 12, 31]. This enlargement in CRF-
OE mice is related to the hypertrophy of the adrenal
cortex, a zone known to be involved in the corticosteroid
synthesis and secretion, while the adrenal medulla is not al-
tered [3, 12, 31]. Consistent with these previous histological
findings [3, 12, 31], there is a high correlation between the
adrenal gland weights and levels of plasma corticosterone
in male and female CRF-OE mice and WT littermates.
Although there was no significant sex difference in cortico-
sterone levels, the correlation indicates to some extent that
enlarged glands lead to high corticosterone production.
CRF-OE male and female mice displayed abdominal
obesity [3, 9, 22] as assessed in the present study by in-
creased weights in perigonadal fat while body weights
were similar to WT of both sexes. Other studies showed
that the weights of perirenal and inguinal fat and the
total body fat content were also increased when assessed
either in male or female CRF transgenic mice [22, 31].
The hypertrophy of abdominal adipose tissue is known
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to occur with glucocorticoid excess [32–34]. Male and
female CRF-OE mice have similar hypercorticosterone-
mia reaching 5.6- and 4.2-fold higher levels than WT
mice, respectively, which is correlated with the epididy-
mal weight. In addition, other studies showed that adre-
nalectomy completely reversed the increased epididymal
and perirenal fat weight observed in CRF-OE mice [22],
indicative that glucocorticoid excess is responsible for
the hypertrophy of visceral adipose tissue. Visceral fat
contains more glucocorticoid receptors than fat in the
subcutaneous regions, which facilitates the development
of abdominal obesity in addition to buffering the excess
of glucocorticoids [34–37]. The loss of sex difference in
body and perigonadal fat weight could be the conse-
quences of sustained high levels of corticosterone [1, 3,
9, 22].
Circulating the levels of insulin, leptin, and acyl ghrelin
under basal and fasted conditions
Under basal conditions, we found that female WT mice
displayed lower basal plasma leptin levels than males
similar to other reports in rats [38, 39], while sex differ-
ence did not exist in CRF-OE mice. These disparities are
likely to be related to the reduced amounts of fat mass
in female WT compared to male WT mice while male
and female CRF-OE mice have similarly increased fat
weights. A previous report showed that male CRF-OE
had elevated plasma insulin levels and hyperglycemia
[22] consistent with our observations. In addition, we
found that both leptin and insulin plasma levels were
similarly increased in both male and female CRF-OE
compared to WT. Circulating leptin and insulin are also
detected to be elevated in other types of obesity such as
induced by high-fat diet, idiopathic, and in patients with
Cushing’s disease [40–42]. The high correlations between
plasma leptin and insulin levels and body fat mass found
in CRF-OE and WT mice also occurred in mice fed a
high-fat diet or in obese humans [40, 43, 44]. In addition,
there was a positive correlation between basal circulating
levels of leptin and insulin with those of corticosterone in
CRF-OE mice. Other reports showed that adrenalectomy
completely prevented the hyperinsulinemia and hypergly-
cemia in male CRF-OE mice [22]. Glucocorticoids may
directly act to stimulate leptin synthesis and release based
on evidence that a half site of the glucocorticoid response
element is present in the 5′-flanking region of the human
leptin gene [45, 46], and leptin synthesis and secretion are
increased by dexamethasone treatment in human or rat
adipocytes [41, 47]. Moreover, adrenalectomy in rats, sur-
gical treatment in Cushing’s patients, and weight loss in
obese subjects are followed by the normalization of
plasma leptin levels and an increase in leptin sensitivity
which coincides with the reversal of glucocorticoid levels
[41, 42, 48]. Collectively, these data support that
glucocorticoids excess itself in CRF-OE is responsible for
the elevated circulating levels of leptin and insulin and the
hyperglycemia.
After an overnight fast, WT females did not show a sig-
nificant reduction in plasma leptin and insulin as observed
in male WT mice, which could be due to the already low
basal levels of these hormones in females. CRF-OE showed
a blunted reduction of leptin in both sexes by fasting which
was also observed in diet-induced obesity (DIO) mice
exposed to a prolonged fast (48 h) [40] and in Zucker (fa/
fa) rats [49]. The significant correlation between leptin and
insulin levels under fasting conditions in mice and humans
[50] is consistent with that the two hormones are function-
ally related to energy homeostasis.
Basal plasma acyl ghrelin levels were lowered in both
male and female CRF-OE mice compared to WT mice.
The factors reducing plasma acyl ghrelin could be related
to the volume of adipose tissues since lower ghrelin levels
are found in different types of obesity [51–53]. It is well
known that fasting reduces plasma levels of insulin and
leptin while acyl ghrelin levels rise in lean rodents [49,
54–56] as also found in male WT mice (present study).
However, fasting did not increase plasma levels of acyl
ghrelin in male and female CRF-OE mice as well as in
female WT mice contrasting with the overnight fasting-
induced increase in plasma total ghrelin previously ob-
served in both male WTand CRF-OE mice [18]. This may
be indicative of an increased ratio of desacyl/acyl ghrelin
reported to occur under stress conditions [57]. Another
report also showed an impaired plasma acyl ghrelin re-
sponse to fasting in genetically obese Zucker rats [58]. In
contrast to CRF-OE mice, acyl ghrelin was increased in
DIO mice with reduced hyperphagia after fasting which
was considered as a stress response [59]. The blunted
increase in acyl ghrelin release by fasting in CRF-OE mice
could result from more complex mechanisms of imbal-
anced hormone levels. Namely, it is known that feeding is
associated with central vagal activation that stimulates
ghrelin release [60] and the overdrive of CRF in the brain
inhibits the vagal preganlionic motor neurons in rats [61].
In the present study, it was unexpected that fasting acyl
ghrelin levels were not increased in female WT littermates
although they ingested more food per body weight com-
pared to male WT mice. This provides the first evidence
of a sex difference in the acyl ghrelin response to an
overnight fast in mice. This is unlikely to be related to
differences in blood glucose levels or hypercorticosterone-
mia found to be similar in male and female WT mice after
fasting. More studies are warranted to ascertain this sex
difference in other rodent species and whether somato-
statin acting on somatostatin 2 receptors located on
gastric ghrelin cells plays a role [62] or gonadal steroid
hormones are involved [63]. However, these data indicate
that the increased feeding response to a fast in female
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compared to male WT mice is not directly related to
changes in circulating acyl ghrelin levels.
The similar plasma levels of PYY and PP in CRF-OE
and WT mice under basal or fasted conditions are indica-
tive that these two hormones do not play a role in the
differential feeding response to a fast in a model of ab-
dominal obesity with chronic HPA stimulation which is
consistent with rodent models of DIO [64]. The high cor-
relation of PYY and PP levels under basal, unlike fasted
conditions, indicates that PYY and PP, released from the
same gut endocrine cells, are functionally related [65, 66].
Alterations in the hypothalamic signals under basal and
fasted conditions
In the brain, NPY and POMC neurons in the arcuate nu-
cleus are key players in regulating energy intake [19, 20].
Signals are mediated via integrating converging peripheral
signals including acyl ghrelin, leptin, and insulin [67]. We
previously reported that male CRF-OE mice exposed to an
overnight fast had a decreased neuronal activation in
arcuate nucleus neurons as shown by the reduced number
of Fos-positive neurons compared to WT mice [18]. We
previously reported that peripheral administration of acyl
ghrelin-induced activation of arcuate nucleus neurons oc-
curred in NPY-synthesizing neurons in mice [68]. It is also
well established that fasting increases hypothalamic NPY
mRNA levels [56, 69]. In the present study, NPY mRNA
levels increased similarly in overnight fasted male and fe-
male WT mice while such a rise was not observed in CRF-
OE mice. By contrast, the suppression of hypothalamic
POMC mRNA levels occurring after a fast in mice [70] was
similar in WT and CRF-OE male mice. These data point to
the altered peripheral acyl ghrelin and hypothalamic NPY
responses to a fast in male CRF-OE male mice as poten-
tially playing a role in the blunted refeeding food intake re-
sponse after an overnight fast. Noticeably, there was a sex
difference in the hypothalamic response to fasting as
showed by the rise in POMC mRNA expression in female
CRF-OE while NPY levels were not modified. However,
both male and female CRF-OE mice had similar inhibition
of feeding response to the fast, suggesting that the increased
POMC anorexic signaling may play a more prominent role
in female CRF-OE. The lack of NPY mRNA rise in the
hypothalamus induced by fasting in female CRF-OE mice
may be related to the already elevated basal level which is
similar to that induced by refeeding in WT mice. Other
studies in mice showed that chronic elevation of NPY over-
expression does not induce changes in feeding behavior
[71], and there is evidence that chronic stress-induced re-
duction of food intake in rodents is associated with elevated
expression of NPY in the arcuate nucleus [72]. It can be
speculated that the elevation of NPY expression in the ar-
cuate nucleus observed selectively in female CRF-OE mice
reflects a counter regulatory anxiolytic mechanism [72] to
reverse enhanced sensitivity of female to brain CRF overex-
pression [11] and induction of anxiety [7].
We also observed an increased leptin receptor levels in
CRF-OE mice which may be related to possible leptin re-
sistance due to truncal obesity, as shown by the correlation
between leptin receptor expression and circulating leptin
levels. The observed sex differences in NPY and POMC
mRNA in CRF-OE mice imply that sex hormones signaling
in the brain modulate the hypothalamic circuits of NPY
and POMC. The underlying mechanisms warrant further
investigation.
Conclusions
CRF-OE mice, known as a model for chronic stress and
Cushing’s disease, display altered circulating endocrine
hormones related to energy balance as shown by the
elevated plasma levels of leptin and insulin and decreased
acyl ghrelin levels associated with adrenal hypertrophy,
hypercorticosteronemia, and increased abdominal fat.
CRF-OE mice lose the sex difference in food intake and
altered metabolic hormone responses to an overnight fast
observed in WT mice (Table 3). This may be related to
the increased corticosterone, insulin and leptin levels, and
visceral fat volume similarly elevated in male and female
CRF-OE mice. The sex difference in the alterations of
hypothalamic NPY and POMC expression in response to
fasting may be an indicative of the differential mechanisms
involved in the inhibition of refeeding between male and
female CRF-OE mice. Whether this reflects a potential
influence of gonadal steroid hormones interaction with
CRF signaling in the brain needs to be further investi-
gated. In addition, the higher adrenal gland volume [3, 12,
31] and blood glucose levels in female than male CRF-OE
Table 3 Summary of alterations in CRF-OE mice and WT littermates
influenced by CRF-OE and fasting with sex difference
Basal Fasting
WT CRF-OE WT CRF-OE
Body weight F < M F↑ ↓ F > M ↓ <WT
Fat F < M ↑ ↓ F < M (−)
Adrenal glands F > M ↑ F >M (−) (−)
Fasting blood glucose (−) ↑ F > M
Refeeding ↑ F > M ↓
Plasma Corticosterone (−) ↑ ↑ (−)
Leptin F < M ↑ M↓ (−)
Insulin (−) ↑ ↓ ↓
Acyl ghrelin (−) ↓ M↑ (−)
PYY (−) (−) M↓ M↓
Hypothalamus NPY (−) F↑ ↑ (−)
POMC (−) (−) M↓ M↓, F↑
LepR (−) ↑ (-) (-)
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mice may be consistent with the elevated locus coeruleus
neuronal activity selectively occurring in female CRF-OE
mice compared to males driving sympathetic outflow [12].
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Figure S7. Correlations of hypothalamic NPY expression with other
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plasma acyl ghrelin in male CRF-OE and WT mice (B), basal levels with
plasma acyl ghrelin in male CRF-OE and WT mice (C), fasting levels with
plasma acyl ghrelin in male CRF-OE and WT mice (D), basal levels with
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